Asar

Hanger Announces Pete Stoy as CEO

Retrieved on: 
Monday, May 1, 2023
General Health, Health, Physical Therapy, Medical Devices, Sodexo, McKesson Corporation, Medication, Hanger, Inc., Organization, Cardinal Health, Stoy, Illinois, Asar, Retirement, Medical-surgical nursing, American College, Management

Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced Pete Stoy, formerly the company’s President and Chief Operating Officer, has assumed the role of Hanger’s Chief Executive Officer (CEO), effective immediately.

Key Points: 
  • Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced Pete Stoy, formerly the company’s President and Chief Operating Officer, has assumed the role of Hanger’s Chief Executive Officer (CEO), effective immediately.
  • Stoy’s appointment was announced in January as part of a multi-year succession plan, and follows the retirement of Vinit Asar who held the CEO position for more than a decade.
  • “I am pleased to pass the torch to Pete Stoy,” shared Asar.
  • Prior to joining Hanger, Stoy served as the Healthcare Business Unit, East Region President for Sodexo.

Hanger Announces CEO Transition Plan

Retrieved on: 
Wednesday, January 18, 2023
General Health, Health, Physical Therapy, Medical Devices, Retirement, McKesson Corporation, American College, Environment, Asar, Education, Organization, Partnership, History, Stoy, Illinois, Cardinal Health, Hanger, Inc., Employment, Management, Sodexo

Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced Chairman and Chief Executive Officer (CEO) Vinit Asar will retire from the role of CEO effective May 1, 2023 after more than a decade in the position.

Key Points: 
  • Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced Chairman and Chief Executive Officer (CEO) Vinit Asar will retire from the role of CEO effective May 1, 2023 after more than a decade in the position.
  • In line with a multi-year succession plan, Hanger’s Chief Operating Officer (COO) Pete Stoy has been named President and COO, and will assume the role of CEO upon Asar’s retirement, in addition to serving on Hanger’s Board of Directors.
  • “It has been my absolute honor to serve as Hanger’s CEO over the past eleven years,” shared Asar.
  • “Vinit has made an indelible impact on Hanger throughout his storied tenure,” stated Stoy.

Hanger, Inc. Announces Definitive Agreement to be Acquired by Patient Square Capital for $18.75 Per Share in Cash

Retrieved on: 
Thursday, July 21, 2022
Health, Medical Devices, Physical Therapy, Corporation, Kirkland & Ellis, Partnership, Person, VWAP, New, Agreement, Foley & Lardner, Review, Calendar, Company, Security (finance), Latham & Watkins, Acquisition, Investment, Asar, U.S. Securities and Exchange Commission, Solution, Compte rendu, Annual, Communication, LP, Industry, CEO, SEC, Health, Failure, Board, COVID-19, Nature, Organization, Health care, Form 10-K, Risk, Islamic finance products, services and contracts, LLP, Plan, Forward-looking statement, NYSE, Sub, Patient, Forbes, Suite, BofA Securities, Risk management, Healthcare, Hanger, Parent, Ownership, Mergers and acquisitions, Shareholder

Patient Square Capital recognizes the value of our brand and the quality of our world-class team, and is grounded in similar values that guide our actions.

Key Points: 
  • Patient Square Capital recognizes the value of our brand and the quality of our world-class team, and is grounded in similar values that guide our actions.
  • They share the same long-term vision for our company, which makes them an excellent partner for the next phase of our journey.
  • Patient Square Capital ( www.patientsquarecapital.com ) is a dedicated health care investment firm that partners with best-in-class management teams whose products, services and technologies improve health.
  • Patient Square invests in businesses that strive to improve patient lives, strengthen communities, and create a healthier world.

Lucid Lane Raises $16 Million Series A From Accel and Battery Ventures to Help People Living with Medication Dependence

Retrieved on: 
Thursday, August 5, 2021
Mental Health, Health, Technology, Mobile, Wireless, Software, Pharmaceutical, Internet, Cloud, Cerner, Asar, CPO, Supercell, Insurance, Mental health, Time, Cancer, Pain, Benzodiazepine, Multimedia, Tricare, Hospital, Stanford University, Shutterfly, Teladoc Health, SVP, Battery Ventures, COO, Medicare, Substance use disorder, Chronic pain, Chief executive officer, Intuit, Anxiety, Pressure, Life, Population, Technology, Pain Clinic, University, DJI, Growth, Depression, Etsy, Quality of life, Dropbox, Yahoo!, MD Anderson Cancer Center, Medical assistant, DocuSign, CTO, Nicotine, Accel, Software, Patient, University of Texas System, CDC, CMS, Jet, Knowledge, UiPath, Physician, MD, Health insurance, Medicine, Healthcare, Pharmaceutical industry, Lucid Lane, Accel, Battery Ventures, LUCID LANE, ACCEL, BATTERY VENTURES

Each year, 40 million people are prescribed opioids and benzodiazepines-- often after surgery or in conjunction with cancer treatment-- in order to address acute and chronic pain as well as co-occurring mental health challenges such as anxiety and depression. These medications work well for a vast majority of the population to address pain and mental health. However, about 15 million people will become persistent users of opioids and benzodiazepines. Their healthcare cost balloons significantly for the insurance health plans and self-insured employers. Lucid Lane provides its comprehensive Medication Taper Management™ service to prevent these patients from becoming persistent medication users and keep them from eventually sliding into addiction.

Key Points: 
  • The round was led by Accel with participation from Battery Ventures, AME Cloud Ventures, Morado Ventures and strategic angel investors.
  • Eric Wolford, Partner at Accel, has joined the Lucid Lane board of directors.
  • Lucid Lane provides its comprehensive Medication Taper Management service to prevent these patients from becoming persistent medication users and keep them from eventually sliding into addiction.
  • The analytics engine detects patients who need help in the moment so that Lucid Lane can connect them instantly with an on-call counselor.